Omolin (Omeprazole)

Omeprazole, the active ingredient in Omolin, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omolin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omolin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omolin is a proton pump inhibitor that acts on the gastric acid secretion pathway to manage acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Helicobacter pylori eradication regimens (as part of combination therapy): enhances eradication rates by suppressing acid. - NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer development in at‑risk patients.

Adverse reactions to Omolin may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas formation. - Constipation: infrequent bowel changes.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reactions. - Osteoporotic fractures: increased risk with long‑term use. - Hepatic dysfunction: elevated liver enzymes.

When prescribing Omolin, clinicians should consider several safety aspects.

- Assess renal function: adjust use in severe impairment. - Evaluate hepatic status: use with caution in liver disease. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term therapy: consider bone health and magnesium levels. - Pregnancy and lactation: weigh benefits against potential risks. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Omolin can interact with several medicines, requiring attention to interaction severity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atorvastatin: increased plasma concentration. - Warfarin: potential alteration of INR.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels. - Methotrexate: reduced renal clearance. - HIV protease inhibitors: altered omeprazole metabolism. - Phenytoin: decreased omeprazole exposure. - Iron supplements: decreased absorption of iron.